Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.
2.

Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.

D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.

Synapse. 2003 Jan;47(1):10-4.

PMID:
12422368
3.

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.

Al-Sweidi S, Morissette M, Bourque M, Di Paolo T.

Neuropharmacology. 2011 Sep;61(4):583-91. doi: 10.1016/j.neuropharm.2011.04.031. Epub 2011 May 11.

PMID:
21586296
4.

Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.

Callier S, Morissette M, Grandbois M, Pélaprat D, Di Paolo T.

Synapse. 2001 Aug;41(2):131-8.

PMID:
11400179
5.

Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1.

Bourque M, Morissette M, Di Paolo T.

Neuropharmacology. 2015 Aug;95:343-52. doi: 10.1016/j.neuropharm.2015.04.006. Epub 2015 Apr 17.

PMID:
25892506
6.

Estrogen receptors and lesion-induced response of striatal dopamine receptors.

Al Sweidi S, Morissette M, Rouillard C, Di Paolo T.

Neuroscience. 2013 Apr 16;236:99-109. doi: 10.1016/j.neuroscience.2012.12.058. Epub 2013 Jan 26.

PMID:
23357113
7.

Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.

D'Astous M, Morissette M, Callier S, Di Paolo T.

J Neurosci Res. 2005 Apr 1;80(1):138-44.

PMID:
15723346
8.
9.
10.

Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.

Ookubo M, Yokoyama H, Takagi S, Kato H, Araki T.

Mol Cell Endocrinol. 2008 Dec 16;296(1-2):87-93. doi: 10.1016/j.mce.2008.07.019. Epub 2008 Aug 6.

PMID:
18755240
11.

Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist.

D'Astous M, Morissette M, Di Paolo T.

Neuropharmacology. 2004 Dec;47(8):1180-8.

PMID:
15567427
12.

Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.

Bourque M, Morissette M, Di Paolo T.

Neurobiol Aging. 2014 Oct;35(10):2347-56. doi: 10.1016/j.neurobiolaging.2014.03.017. Epub 2014 Mar 20.

PMID:
24726471
13.

Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N, Estrada-Camarena E, Mendez P, Garcia-Segura LM, Di Paolo T.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):327-38. Epub 2007 Sep 7. Review.

PMID:
17936613
14.

The impact of gender and estrogen on striatal dopaminergic neurotoxicity.

Miller DB, Ali SF, O'Callaghan JP, Laws SC.

Ann N Y Acad Sci. 1998 May 30;844:153-65.

PMID:
9668673
15.

Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity.

Morissette M, Jourdain S, Al Sweidi S, Menniti FS, Ramirez AD, Di Paolo T.

Neuropharmacology. 2007 Jun;52(7):1509-20. Epub 2007 Mar 2.

PMID:
17420033
16.

ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens.

Le Saux M, Morissette M, Di Paolo T.

Neuropharmacology. 2006 Mar;50(4):451-7. Epub 2005 Nov 23.

PMID:
16309717
17.

Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.

Al Sweidi S, Sánchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T.

J Neuroendocrinol. 2012 Jan;24(1):48-61. doi: 10.1111/j.1365-2826.2011.02193.x. Review.

PMID:
21790809
18.

Estrogen and SERM neuroprotection in animal models of Parkinson's disease.

Morissette M, Al Sweidi S, Callier S, Di Paolo T.

Mol Cell Endocrinol. 2008 Aug 13;290(1-2):60-9. doi: 10.1016/j.mce.2008.04.008. Epub 2008 Apr 22. Review.

PMID:
18515001
19.

Supplemental Content

Support Center